A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of DP-R206 and Bonvia for the improvement of Vitamin D In postmenopausal women with Osteoporosis ; DIOS study
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Colecalciferol/ibandronic-acid (Primary) ; Ibandronic acid
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- Acronyms DIOS
- Sponsors DreamPharma Corporation
- 31 Oct 2016 Status changed from recruiting to completed.
- 09 May 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000415).
- 26 Apr 2012 New trial record